Dose effect analysis of sodium zirconium cyclosilicate in hemodialysis patients

被引:3
|
作者
Spinowitz, Bruce [1 ]
McCafferty, Kieran [2 ]
Fishbane, Steven [3 ]
Fukagawa, Masafumi [4 ]
Guzman, Nicolas [5 ]
Ford, Martin [6 ,7 ]
Rastogi, Anjay [8 ]
Bhandari, Sunil [9 ]
机构
[1] NewYork Presbyterian Queens, Dept Med, Queens, NY USA
[2] Barts Hlth NHS Trust, Dept Nephrol, London, England
[3] Donald & Barbara Zucker Sch Med Hofstra Northwell, Dept Med, Great Neck, NY USA
[4] Tokai Univ, Sch Med, Dept Internal Med, Div Nephrol Endocrinol & Metab, Isehara, Kanagawa, Japan
[5] AstraZeneca BioPharmaceut Res & Dev, Global Med Dev, Gaithersburg, MD USA
[6] Kings Coll Hosp NHS Trust, Dept Renal Med, London, England
[7] Kings Coll London, Fac Life Sci & Med, London, England
[8] Univ Calif Los Angeles, UCLA CORE Kidney Program, Los Angeles, CA USA
[9] Hull Univ Teaching Hosp NHS Trust, Dept Renal & Transplant Med, Kingston Upon Hull, N Humberside, England
关键词
dose; fluid balance; hemodialysis; hyperkalemia; potassium; sodium zirconium cyclosilicate;
D O I
10.1111/hdi.12983
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:274 / 277
页数:4
相关论文
共 50 条
  • [31] Letter to the editor regarding "Patiromer and Sodium Zirconium Cyclosilicate in Treatment of Hyperkalemia: A Systematic Review and Meta-analysis: Patiromer and Sodium Zirconium Cyclosilicate in Hyperkalemia'
    Zarzuela, Donna
    Bhalla, Narinder
    CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 2021, 95
  • [32] Clinical Implications of Sodium Zirconium Cyclosilicate Therapy in Patients with Systolic Heart Failure and Hyperkalemia
    Imamura, Teruhiko
    Oshima, Akira
    Narang, Nikhil
    Kinugawa, Koichiro
    JOURNAL OF CLINICAL MEDICINE, 2021, 10 (23)
  • [33] Sodium Zirconium Cyclosilicate for the Acute Management of Hyperkalemia in the Emergency Department
    Gasparovic, Nicole
    Buckallew, Amanda
    Richter, Sara
    ANNALS OF PHARMACOTHERAPY, 2025,
  • [34] Radiopacity of sodium zirconium cyclosilicate on CT imaging
    Kolesnik, Michael
    Berezovsky, David
    Sayegh, Martin
    Samarneh, Majed
    CEN CASE REPORTS, 2021, 10 (04) : 559 - 562
  • [35] Sodium Zirconium Cyclosilicate for Management of Hyperkalemia During Spironolactone Optimization in Patients With Heart Failure
    Kosiborod, Mikhail N.
    Cherney, David Z. I.
    Desai, Akshay S.
    Testani, Jeffrey M.
    Verma, Subodh
    Chinnakondepalli, Khaja
    Dolling, David
    Patel, Shachi
    Dahl, Magnus
    Eudicone, James M.
    Friberg, Lovisa
    Ouwens, Mario
    Antunes, Murillo O.
    Connelly, Kim A.
    Madrini, Vagner
    Kuthi, Luca
    Lala, Anuradha
    Lorenzo, Miguel
    Guimaraes, Patricia O.
    Marcos, Marta Cobo
    Merkely, Bela
    Nunez, Julio
    Squire, Iain
    Vaclavik, Jan
    Wranicz, Jerzy
    Petrie, Mark C.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2025, 85 (10) : 971 - 984
  • [37] Pharmacodynamics and pharmacokinetics of sodium zirconium cyclosilicate [ZS-9] in the treatment of hyperkalemia
    Packham, David K.
    Kosiborod, Mikhail
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2016, 12 (05) : 567 - 573
  • [38] Cost analysis of patiromer vs sodium zirconium cyclosilicate for the treatment of hyperkalemia in Spain and the UK
    de Arellano, Antonio Ramirez
    Jakutis, Gabrielius
    Hunt, Barnaby
    JOURNAL OF MEDICAL ECONOMICS, 2024, 27 (01) : 1011 - 1017
  • [39] Cost-effectiveness of sodium zirconium cyclosilicate for advanced chronic kidney patients in Singapore
    Chay, Junxing
    Choo, Jason C. J.
    Finkelstein, Eric A.
    NEPHROLOGY, 2024, 29 (05) : 278 - 287
  • [40] A Phase 1, open-label, crossover study evaluating the effect of a single dose of sodium zirconium cyclosilicate on the pharmacokinetics of tacrolimus and cyclosporin
    Nagard, Mats
    Choudhury, Nurul
    Lisovskaja, Vera
    Mackillop, Neil
    Al-Shurbaji, Ayman
    CLINICAL KIDNEY JOURNAL, 2023, 16 (01) : 151 - 158